LENT Prognostic Score for Malignant Pleural Effusion

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: U/L

حداقل ۰ — حداکثر ۱۰۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
lent score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–1
  • Moderate Risk2–4
  • High Risk5–7
Direct Clinical Answer

The LENT Prognostic Score for Malignant Pleural Effusion calculator is designed for bedside predicting survival in patients with malignant pleural effusion using clinical and laboratory parameters to help inform treatment decisions and prognosis discussions in clinical practice. The resulting score directly guides clinician decision-making regarding.

Clinical Guidelines & Evidence

Predicts survival in patients with malignant pleural effusion using clinical and laboratory parameters to help inform treatment decisions and prognosis discussions

Clinical Indication

The LENT Prognostic Score for Malignant Pleural Effusion is indicated for bedside clinical practice to support Predicts survival in patients with malignant pleural effusion using clinical and laboratory parameters to help inform treatment decisions and prognosis discussions. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: Not meant to replace clinical judgment in treatment decisions.

Formula & Variables:

LENT Score = LDH points + ECOG points + Neutrophil-lymphocyte ratio points + Tumor type points

Input Parameters

NameTypeRequiredDescription
pleural_fluid_ldhfloatYesPleural fluid lactate dehydrogenase (LDH) level(U/L)
ecog_performance_statusintegerYesEastern Cooperative Oncology Group (ECOG) Performance Status scale
neutrophil_lymphocyte_ratiofloatYesSerum neutrophil-to-lymphocyte ratio
tumor_typestringYesPrimary tumor type

Score Interpretation & Guidance

RangeStageDescription
0–1Low RiskLow risk of mortality
2–4Moderate RiskModerate risk of mortality
5–7High RiskHigh risk of mortality

Evidence-Based References (EBM)

  • Clive AO, Kahan BC, Hopwood BE, Bhatnagar R, Morley AJ, Zahan-Evans N, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014 Dec;69(12):1098-104.
  • Psallidas I, Kanellakis NI, Gerry S, Theza A, Saba T, Tsim S, et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. Lancet Oncol. 2018 Jul;19(7):930-939.
  • Porcel JM. Malignant pleural effusion. Current opinion in Pulmonary Medicine. 2016 Jul;22(4):356-61.

Related calculators